|
|
Los Angeles, Jan 28 (IANS) Marvel's 'Ant-Man' franchise star Evangeline Lilly took to Instagram, revealing that she was at a Washington DC rally in "support of bodily sovereignty," and protesting Covid vaccine mandates.
"I believe nobody should ever be forced to inject their body with anything, against their will, under threat of: violent attack, arrest or detention without trial, loss of employment, homelessness, starvation, loss of education, alienation from loved ones, excommunication from society under any threat whatsoever," wrote the actress.
"This is not the way. This is not safe. This is not healthy. This is not love. I understand the world is in fear, but I don't believe that answering fear with force will fix our problems," she added.
In fact, nearly every medical body of any merit says there is nothing to fear from Covid vaccines. Most strongly encourage them including the American Medical Association, the American Academy of Pediatrics and the Centre for Disease Contol, reports deadline.com.
Lilly added: "I was pro choice before Covid and I am still pro choice today."
Lilly is the second Marvel actress to have expressed reservations against vaccines.
In 2020, Black Panther star Letitia Wright shared an anti-vax video on social media, then temporarily deactivated her Twitter and Instagram accounts before apologising and saying she didn't mean to hurt anyone.
Also in 2020, Lilly wrote on Instagram that she would not social distance.
She later walked back those comments saying: "want to offer my sincere and heartfelt apology for the insensitivity I showed in my previous post to the very real suffering and fear that has gripped the world through Covid-19."
"Grandparents, parents, children, sisters and brothers are dying, the world is rallying to find a way to stop this very real threat, and my ensuing silence has sent a dismissive, arrogant and cryptic message."
Lilly plays Hope van Dyne in the 'Ant-Man' franchise. 'Ant-Man and the Wasp: Quantumania' has wrapped and will be seen in theaters on July 28, 2023.
